Please login to the form below

Not currently logged in
Email:
Password:

design

This page shows the latest design news and features for those working in and with pharma, biotech and healthcare.

Roche's O’Day swaps big pharma for big biotech

Roche's O’Day swaps big pharma for big biotech

Among Gilead's moves is a shift into immuno-oncology via the acquisition of CAR-T specialist   Kite Pharma for almost $12bn and smaller player Cell Design Labs, a $3bn agreement

Latest news

More from news
Approximately 24 fully matching, plus 699 partially matching documents found.

Latest Intelligence

  • How industry platforms can help transform outcomes-based contracting in healthcare How industry platforms can help transform outcomes-based contracting in healthcare

    While there has been some experimentation with OBCs recently, pervasive stakeholder concerns that they are too risky, too complex to design and measure, and too difficult to replicate across multiple parties ... Three design principles. In order to

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    The design of such neuroprotective studies may benefit from the lessons learned in studies in the most common neurodegenerative disease, Alzheimer’s. ... Adaptive design at phase 2 development can be a very effective approach to explore dosage range

  • Nudge-nudge, think-think Nudge-nudge, think-think

    Our success will depend on making sure that the interventions we design are tangible and realistic for the end user. ... This requires an agile, iterative design cycle where interventions can be built, tested and implemented at pace.”.

  • Leave or remain? Winning the employee referendum Leave or remain? Winning the employee referendum

    There’s huge scope for much smarter bonus design where employees can share in a company’s success.

  • A little less conversation

    From insight, through intervention strategy, to solution co-design, optimising and testing, it’s the patients who drive the decision-making. ... We believe, therefore, that patients should be at the heart of every decision and solution design in

More from intelligence
Approximately 2 fully matching, plus 172 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 47 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 38 fully matching, plus 363 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics